antibody therapeutics reimagined
Antibody therapeutics reimagined
antibody ren

Our Mission

The Chinese character “ren” means people and humanity. RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone.

Our Mission

Our Mission

advance first-in-class and best-in-class DNA therapeutic technologies to humans

Our Vision

Our Vision

modernize and transform the antibody and therapeutic protein fields to significantly reduce the impact of diseases worldwide

Our Goals

Our Goals

deliver antiviral antibodies to prevent the spread of infectious diseases and improve the dosing regimen and effectiveness of therapeutic proteins

Our Values

Excellence

Curiosity

Thoughtful
Action

Collective
Wisdom

Optimism

Our Mission
advance first-in-class and best-in-class DNA therapeutic technologies to humans
Our Vision
modernize and transform  the antibody and  therapeutic protein fields to significantly reduce the impact of diseases worldwide
Our Goals
deliver antiviral antibodies to prevent the spread of infectious diseases and improve the dosing regimen and effectiveness of therapeutic proteins
Previous
Next

Our Values

Excellence

Curiosity

Thoughtful Action

Collective Wisdom

Optimism

Antibody and Protein
Therapeutics, Reimagined

Antibody and protein therapeutics can provide an overwhelming benefit for human health, but major obstacles in their administration, efficacy, durability, and cost limit their more widespread use. We have reimagined the way antibody and protein therapeutics can be produced and delivered to overcome these obstacles.

Our delivery platform takes advantage of the body’s ability to produce any given antibody or therapeutic protein when provided with the precise set of genetic instructions. These instructions, encoded in DNA, are biological blueprints.

MYO technology data-lazy-srcset=

Make Your Own

Using RenBio’s Make Your Own (MYO) Technology, therapeutic encoding “bioblueprints” are delivered via modified intramuscular injection which are then decoded by the muscle cells to produce disease-fighting therapeutics in the patient’s own body.
scientist renbio

Monoclonal Antibodies

Best-in-class engineered antibodies to significantly reduce the impact of diseases that could benefit from antibody therapeutics

A Dedicated Team

RenBio was co-founded by Drs. David Ho and Yaoxing Huang, visionary scientists affiliated with the Aaron Diamond AIDS Research Center in New York City. Since opening our doors in 2016, we have rapidly grown into a diverse, multidisciplinary team, with expertise spanning a range of biological and engineering fields. Our approach leverages the breadth of our collective knowledge to develop a true platform technology with the ability to deliver antibodies for the prevention and treatment of multiple diseases.

Our Funders

darpa logo data-lazy-srcset=
Bill & Melinda Gates foundation logo data-lazy-srcset=
Ren_Bio_Site_Home_5-Copy-3d.png
Ruentex_02.png

Contact

If you have any questions or comments, or if you are interested in joining our team, you can send us a message using the form below.  We are always seeking exceptional talent; if you are a creative, highly motivated individual interested in working in a fast-paced, multidisciplinary, collaborative environment, tell us about yourself and why you are interested in joining us!